Boule Diagnostics AB (OSTO:BOUL) Cash-to-Debt : 0.23 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Boule Diagnostics AB Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Boule Diagnostics AB's cash to debt ratio for the quarter that ended in Mar. 2024 was 0.23.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Boule Diagnostics AB couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Boule Diagnostics AB's Cash-to-Debt or its related term are showing as below:

OSTO:BOUL' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.11 Med: 0.34 Max: 1.52
Current: 0.23

During the past 13 years, Boule Diagnostics AB's highest Cash to Debt Ratio was 1.52. The lowest was 0.11. And the median was 0.34.

OSTO:BOUL's Cash-to-Debt is ranked worse than
84.15% of 839 companies
in the Medical Devices & Instruments industry
Industry Median: 1.98 vs OSTO:BOUL: 0.23

Boule Diagnostics AB Cash-to-Debt Historical Data

The historical data trend for Boule Diagnostics AB's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Boule Diagnostics AB Cash-to-Debt Chart

Boule Diagnostics AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.14

0.26

0.25

0.51

0.22

Boule Diagnostics AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															0.34	0.25	0.28	0.22	0.23

Competitive Comparison of Boule Diagnostics AB's Cash-to-Debt

For the Medical Devices subindustry, Boule Diagnostics AB's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boule Diagnostics AB's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boule Diagnostics AB's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Boule Diagnostics AB's Cash-to-Debt falls into.

Boule Diagnostics AB Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Boule Diagnostics AB's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	37.281	/	(97.48	+	68.693)
	=	0.22

Boule Diagnostics AB's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	40.9	/	(105	+	73.4)
	=	0.23

Boule Diagnostics AB (OSTO:BOUL) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Boule Diagnostics AB Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Boule Diagnostics AB's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Boule Diagnostics AB (OSTO:BOUL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boule Diagnostics AB (OSTO:BOUL) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Domnarvsgatan 4, Spanga, SWE, SE-163 53

Website

https://www.boule.com

Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The firm focuses on the decentralized market segment. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. Through its subsidiaries, the Group operates in Sweden, USA, and China.

Boule Diagnostics AB (OSTO:BOUL) Headlines

No Headlines